July 25, 2000
A Utah company is once again the center of
controversy. It's another battle over dietary
suppliments.
A Federal judge in Denver says
Provo-based NuSkin is subject to government
regulations on a product to reduce cholesterol. News
Specialist Richard Piatt tells how it could affect you.
If you use dietary supplements, you will be interested
in this case. That's because it taps into a major issue:
Should the government regulate supplements?
The F.D.A. argues cholesterol reducing 'Cholestin' has
an ingredient that should be regulated. That ingredient,
Mavinolin, occurs naturally in China-grown red yeast
rice.
But the issue goes beyond Mavinolin, and Cholestin,
and into the $30 billion a year dietary supplement
industry. That's why NuSkin Enterprises, which makes
Cholestin, plans to keep pushing its court fight.
IT'S IMPORTANT FOR US AND IMPORTANT
FOR CONSUMERS TO UNDERSTAND TO WHAT
LENGTH THE GOVERNMENT IS GOING TO
REGULATE DIETARY SUPPLEMENTS AND
HEALTH FOODS.
Cholestin is the first supplement to undergo the
scrutiny of the courts since Congress passed 1994's
Dietary Supplement Health and Education Act.
The
law allows all kinds of herbs, teas, and supplements to
go on sale, even though they're not approved by the
F.D.A.
Some, like GHB and Ephedra, have proven to be
dangerous when abused, leading some to push for
more F.D.A. oversight.
NuSkin argues that if safety
were an issue, the F.D.A. could pick one of these
drugs for a court battle. Supplements like Cholestin,
they argue, have not been found to be dangerous, and
in fact NuSkin argues it's beneficial.
People who take
supplements don't seem concerned about the safety
issue.
I THINK THEY SHOULD BE AVAILABLE TO
PEOPLE. I THINK IT WOULD HURT THEIR
AVAILABILITY IF THEY WERE
REGULATED.
I'M CONCERNED ABOUT THEIR
REGULATING PEOPLE, TAKING OVER
THEIR NATURAL HEALTH AND WELL
BEING.
NuSkin-owned Pharmanex continues to sell Cholestin
directly to consumers. It will continue to do so even
while it continues it's court battle with the F.D.A.
Federal Judge Dale Kimball, based in Salt Lake City,
originally ruled with NuSkin on this issue. The court of
appeals decision now throws the issue back in his
Utah court to consider again.